Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-κB and other signal transcription factors in head and neck squamous cell carcinoma

Genome Biology

Volumn 8, Issue 5, 2007, Pages

  Yan, Bin ^a   Yang, Xinping ^a   Lee, Tin Lap ^b   Friedman, Jay ^a   Tang, Jun ^c   Van Waes, Carter ^a   Chen, Zhong ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; EARLY GROWTH RESPONSE FACTOR 1; GENOMIC DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ADULT; AGED; ANIMAL CELL; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CHROMATIN STRUCTURE; CONTROLLED STUDY; DNA MICROARRAY; GENE CLUSTER; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENOME ANALYSIS; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; KERATINOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN MOTIF; REGULATORY MECHANISM; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION; GENETICS; GENOME; HEAD AND NECK TUMOR; REGULATORY SEQUENCE;

VERTEBRATA;

BINDING SITES; CARCINOMA, SQUAMOUS CELL; CLUSTER ANALYSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HEAD AND NECK NEOPLASMS; HUMANS; NF-KAPPA B; REGULATORY ELEMENTS, TRANSCRIPTIONAL; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34548815292     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2007-8-5-r78     Document Type: Article

References (116)

1. Jeon GA Lee JS Patel V Gutkind JS Thorgeirsson SS Kim EC Chu IS Amornphimoltham P Park MH Global gene expression profiles of human head and neck squamous carcinoma cell lines. Int J Cancer 2004 112 249 258 10.1002/ijc.20399 15352037
2. Warner GC Reis PP Makitie AA Sukhai MA Arora S Jurisica I Wells RA Gullane P Irish J Kamel-Reid S Current applications of microarrays in head and neck cancer research. Laryngoscope 2004 114 241-248 10.1097/ 00005537-200402000-00013 14755198
3. Choi P Chen C Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer 2005 104 1113-1128 10.1002/cncr.21293 16092115
4. Gonzalez HE Gujrati M Frederick M Henderson Y Arumugam J Spring PW Mitsudo K Kim HW Clayman GL Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003 129 754-759 10.1001/archotol.129.7.754 12874078
5. Akervall J Guo X Qian CN Schoumans J Leeser B Kort E Cole A Resau J Bradford C Carey T et al Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients. Clin Cancer Res 2004 10 8204-8213 10.1158/1078-0432.CCR-04-0722 15623595
6. Ginos MA Page GP Michalowicz BS Patel KJ Volker SE Pambuccian SE Ondrey FG Adams GL Gaffney PM Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004 64 55-63 10.1158/0008-5472.CAN-03-2144 14729608
7. Chung CH Parker JS Karaca G Wu J Funkhouser WK Moore D Butterfoss D Xiang D Zanation A Yin X et al Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 2004 5 489-500 10.1016/S1535-6108(04)00112-6 15144956
8. Hunter KD Thurlow JK Fleming J Drake PJ Vass JK Kalna G Higham DJ Herzyk P Macdonald DG Parkinson EK et al Divergent routes to oral cancer. Cancer Res 2006 66 7405-7413 10.1158/0008-5472.CAN-06-0186 16885335
9. Roepman P Kemmeren P Wessels LF Slootweg PJ Holstege FC Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. Cancer Res 2006 66 2361-2366 10.1158/0008-5472.CAN-05-3960 16489042
10. Fickett JW Wasserman WW Discovery and modeling of transcriptional regulatory regions. Curr Opin Biotechnol 2000 11 19-24 10.1016/ S0958-1669(99)00049-X 10679343
11. Sionov RV Haupt Y The cellular response to p53: The decision between life and death. Oncogene 1999 18 6145-6157 10.1038/sj.onc.1203130 10557106
12. Heinrichs S Deppert W Apoptosis or growth arrest: Modulation of the cellular response to p53 by proliferative signals. Oncogene 2003 22 555-571 10.1038/sj.onc.1206138 12555069
13. Hollstein M Sidransky D Vogelstein B Harris CC p53 mutations in human cancers. Science 1991 253 49-53 10.1126/science.1905840 1905840
14. Olivier M Eeles R Hollstein M Khan MA Harris CC Hainaut P The IARC TP53 database: New online mutation analysis and recommendations to users. Hum Mutat 2002 19 607-614 10.1002/humu.10081 12007217
15. Vousden KH Lu X Live or let die: The cell's response to p53. Nat Rev Cancer 2002 2 594-604 10.1038/nrc864 12154352
16. Brennan JA Boyle JO Koch WM Goodman SN Hruban RH Eby YJ Couch MJ Forastiere AA Sidransky D Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995 332 712-717 10.1056/NEJM199503163321104 7854378
17. Melhem MF Law JC el-Ashmawy L Johnson JT Landreneau RJ Srivastava S Whiteside TL Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers. Am J Pathol 1995 146 1170-1177 1869296 7747811
18. Nylander K Schildt EB Eriksson M Magnusson A Mehle C Roos G A non-random deletion in the p53 gene in oral squamous cell carcinoma. Br J Cancer 1996 73 1381-1386 8645583
19. Quon H Liu FF Cummings BJ Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 2001 23 147-159 10.1002/ 1097-0347(200102)23:2<147::AID-HED1010>3.0.CO;2-# 11303632
20. Blons H Laurent-Puig P TP53 and head and neck neoplasms. Hum Mutat 2003 21 252-257 10.1002/humu.10171 12619110
21. Ondrey FG Dong G Sunwoo J Chen Z Wolf JS Crowl-Bancroft CV Mukaida N Van Waes C Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol Carcinog 1999 26 119-129 10.1002/ (SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N 10506755
22. Duffey DC Chen Z Dong G Ondrey FG Wolf JS Brown K Siebenlist U Van Waes C Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo. Cancer Res 1999 59 3468-3474 10416612
23. Duan J Friedman J Nottingham L Chen Z Ara G Van Waes C Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101. Mol Cancer Ther 2007 6 37-50 10.1158/1535-7163.MCT-05-0285 17237265
24. Wolf JS Chen Z Dong G Sunwoo JB Bancroft CC Capo DE Yeh NT Mukaida N Van Waes C IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin Cancer Res 2001 7 1812-1820 11410524
25. Bancroft CC Chen Z Yeh J Sunwoo JB Yeh NT Jackson S Jackson C Van Waes C Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer 2002 99 538-548 10.1002/ijc.10398 11992543
26. Yu M Yeh J Van Waes C Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells. Cancer Res 2006 66 6722-6731 1839920 16818647 10.1158/0008-5472.CAN-05-3758
27. Pahl HL Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999 18 6853-6866 10.1038/sj.onc.1203239 10602461
28. Richmond A Nf-kappa B, chemokine gene transcription and tumour growth. Nat Rev Immunol 2002 2 664-674 10.1038/nri887 12209135
29. Li JJ Westergaard C Ghosh P Colburn NH Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res 1997 57 3569-3576 9270030
30. Hong SH Ondrey FG Avis IM Chen Z Loukinova E Cavanaugh PF Jr Van Waes C Mulshine JL Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: A general role for inflammation? Faseb J 2000 14 1499 -507 10.1096/fj.14.11.1499 10928984
31. Grandis JR Drenning SD Zeng Q Watkins SC Melhem MF Endo S Johnson DE Huang L He Y Kim JD Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci USA 2000 97 4227-4232 18206 10760290 10.1073/pnas.97.8.4227
32. Song JI Grandis JR STAT signaling in head and neck cancer. Oncogene 2000 19 2489-2495 10.1038/sj.onc.1203483 10851047
33. Lee TL Yeh J Van Waes C Chen Z Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/ or MEK in head and neck squamous cell carcinomas. Mol Cancer Ther 2006 5 8-19 10.1158/1535-7163.MCT-05-0069 16432158
34. Gerdes MJ Myakishev M Frost NA Rishi V Moitra J Acharya A Levy MR Park SW Glick A Yuspa SH et al Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res 2006 66 7578-7588 10.1158/ 0008-5472.CAN-06-1247 16885357
35. Cao XM Koski RA Gashler A McKiernan M Morris CF Gaffney R Hay RV Sukhatme VP Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol Cell Biol 1990 10 1931-1939 360539 2109185
36. Worden B Yang XP Lee TL Bagain L Yeh NT Cohen JG Van Waes C Chen Z Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma. Cancer Res 2005 65 7071-7080 10.1158/ 0008-5472.CAN-04-0989 16103054
37. Dong G Loukinova E Chen Z Gangi L Chanturita TI Liu ET Van Waes C Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway. Cancer Res 2001 61 4797-4808 11406555
38. Loercher A Lee TL Ricker JL Howard A Geoghegen J Chen Z Sunwoo JB Sitcheran R Chuang EY Mitchell JB et al Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. Cancer Res 2004 64 6511-6523 10.1158/0008-5472.CAN-04-0852 15374962
39. Zhang MQ Large-scale gene expression data analysis: A new challenge to computational biologists. Genome Res 1999 9 681-688 10447504
40. Brazma A Vilo J Gene expression data analysis. FEBS Lett 2000 480 17-24 10.1016/S0014-5793(00)01772-5 10967323
41. Bradford CR Zhu S Ogawa H Ogawa T Ubell M Narayan A Johnson G Wolf GT Fisher SG Carey TE P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck 2003 25 654-661 10.1002/hed.10274 12884349
42. Chen Z Colon I Ortiz N Callister M Dong G Pegram MY Arosarena O Strome S Nicholson JC Van Waes C Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines. Cancer Res 1998 58 3668-3676 9721877
43. Kato T Duffey DC Ondrey FG Dong G Chen Z Cook JA Mitchell JB Van Waes C Cisplatin and radiation sensitivity in human head and neck squamous carcinomas are independently modulated by glutathione and transcription factor NF-kappaB. Head Neck 2000 22 748-759 10.1002/ 1097-0347(200012)22:8<748::AID-HED2>3.0.CO;2-6 11084634
44. Lee TL Yang X Yan B Freidman J Duggal P Bagain L Geoghegan J Dong G Yeh TN Wang J et al A novel NF-kappaB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status. Clin Cancer Res 2007
45. Simon R Lam A Li M Ngan M Menenzes M Zhao Y Analysis of gene expression data using BRB-Array Tools. Cancer Informatics 2007 2 11-17
46. Draghici S Khatri P Martins RP Ostermeier GC Krawetz SA Global functional profiling of gene expression. Genomics 2003 81 98 104 10.1016/ S0888-7543(02)00021-6 12620386
47. Loukinova E Chen Z Van Waes C Dong G Expression of proangiogenic chemokine Gro 1 in low and high metastatic variants of Pam murine squamous cell carcinoma is differentially regulated by IL-1alpha, EGF and TGF-beta1 through NF-kappaB dependent and independent mechanisms. Int J Cancer 2001 94 637-644 10.1002/ijc.1514 11745457
48. Dong G Chen Z Li ZY Yeh NT Bancroft CC Van Waes C Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res 2001 61 5911-5918 11479233
49. Bancroft CC Chen Z Dong G Sunwoo JB Yeh N Park C Van Waes C Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. Clin Cancer Res 2001 7 4350-442 11234901
50. Baron V Adamson ED Calogero A Ragona G Mercola D The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther 2006 13 115-124 10.1038/sj.cgt.7700896 16138117
51. el-Deiry WS Regulation of p53 downstream genes. Semin Cancer Biol 1998 8 345 357 10.1006/scbi.1998.0097 10101800
52. Somasundaram K Tumor suppressor p53: Regulation and function. Front Biosci 2000 5 D424-D437 10.2741/Somasund 10762600
53. Liu HS Pan CE Liu QG Yang W Liu XM Effect of NF-kappaB and p38 MAPK in activated monocytes/macrophages on pro-inflammatory cytokines of rats with acute pancreatitis. World J Gastroenterol 2003 9 2513-2518 14606087
54. Morgenstern B Frech K Dress A Werner T DIALIGN: Finding local similarities by multiple sequence alignment. Bioinformatics 1998 14 290-294 10.1093/bioinformatics/14.3.290 9614273
55. Werner T Fessele S Maier H Nelson PJ Computer modeling of promoter organization as a tool to study transcriptional coregulation. Faseb J 2003 17 1228-1237 10.1096/fj.02-0955rev 12832287
56. Hunter KD Parkinson EK Harrison PR Profiling early head and neck cancer. Nat Rev Cancer 2005 5 127-135 10.1038/nrc1549 15685196
57. Webster GA Perkins ND Transcriptional cross talk between NF-kappaB and p53. Mol Cell Biol 1999 19 3485-3495 84141 10207072
58. Rocha S Martin AM Meek DW Perkins ND p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. Mol Cell Biol 2003 23 4713-4727 164841 12808109 10.1128/ MCB.23.13.4713-4727.2003
59. Rocha S Garrett MD Campbell KJ Schumm K Perkins ND Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor. Embo J 2005 24 1157-1169 556410 15775976 10.1038/ sj.emboj.7600608
60. Raman V Martensen SA Reisman D Evron E Odenwald WF Jaffee E Marks J Sukumar S Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 2000 405 974-978 10.1038/35016125 10879542
61. Kang JH Kim SJ Noh DY Park IA Choe KJ Yoo OJ Kang HS Methylation in the p53 promoter is a supplementary route to breast carcinogenesis: correlation between CpG methylation in the p53 promoter and the mutation of the p53 gene in the progression from ductal carcinoma in situ to invasive ductal carcinoma. Lab Invest 2001 81 573-579 11304577
62. Rocco JW Leong CO Kuperwasser N DeYoung MP Ellisen LW p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 2006 9 45-56 10.1016/j.ccr.2005.12.013 16413471
63. Luger K Rechsteiner TJ Flaus AJ Waye MM Richmond TJ Characterization of nucleosome core particles containing histone proteins made in bacteria. J Mol Biol 1997 272 301-311 10.1006/jmbi.1997.1235 9325091
64. Bassing CH Chua KF Sekiguchi J Suh H Whitlow SR Fleming JC Monroe BC Ciccone DN Yan C Vlasakova K et al Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci USA 2002 99 8173-8178 123040 12034884 10.1073/ pnas.122228699
65. Martini EM Keeney S Osley MA A role for histone H2B during repair of UV-induced DNA damage in Saccharomyces cerevisiae. Genetics 2002 160 1375-1387 1462056 11973294
66. Zhang Y Transcriptional regulation by histone ubiquitination and deubiquitination. Genes Dev 2003 17 2733-2740 10.1101/gad.1156403 14630937
67. Minsky N Oren M The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Mol Cell 2004 16 631-639 10.1016/ j.molcel.2004.10.016 15546622
68. Yu X Caltagarone J Smith MA Bowser R DNA damage induces cdk2 protein levels and histone H2B phosphorylation in SH-SY5Y neuroblastoma cells. J Alzheimers Dis 2005 8 7-21 16155345
69. Espinosa JM Emerson BM Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell 2001 8 57-69 10.1016/S1097-2765(01)00283-0 11511360
70. Chen Z Malhotra PS Thomas GR Ondrey FG Duffey DC Smith CW Enamorado I Yeh NT Kroog GS Rudy S et al Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 1999 5 1369-1379 10389921
71. Chung CH Parker JS Ely K Carter J Yi Y Murphy BA Ang KK El-Naggar AK Zanation AM Cmelak AJ et al Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-{kappa}b signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res 2006 66 8210-8218 10.1158/ 0008-5472.CAN-06-1213 16912200
72. Welty SE Rivera JL Elliston JF Smith CV Zeb T Ballantyne CM Montgomery CA Hansen TN Increases in lung tissue expression of intercellular adhesion molecule-1 are associated with hyperoxic lung injury and inflammation in mice. Am J Respir Cell Mol Biol 1993 9 393-400 8104435
73. Colletti LM Cortis A Lukacs N Kunkel SL Green M Strieter RM Tumor necrosis factor up-regulates intercellular adhesion molecule 1, which is important in the neutrophil-dependent lung and liver injury associated with hepatic ischemia and reperfusion in the rat. Shock 1998 10 182-191 9744646
74. Kacimi R Karliner JS Koudssi F Long CS Expression and regulation of adhesion molecules in cardiac cells by cytokines: Response to acute hypoxia. Circ Res 1998 82 576-586 9529162
75. Stanciu LA Djukanovic R The role of ICAM-1 on T-cells in the pathogenesis of asthma. Eur Respir J 1998 11 949-957 10.1183/ 09031936.98.11040949 9623703
76. Bavendiek U Libby P Kilbride M Reynolds R Mackman N Schonbeck U Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. J Biol Chem 2002 277 25032-25039 10.1074/jbc.M204003200 11978801
77. Thyss R Virolle V Imbert V Peyron JF Aberdam D Virolle T NF-kappaB/Egr-1/ Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death. Embo J 2005 24 128-137 544913 15616591 10.1038/ sj.emboj.7600501
78. Squarize CH Castilho RM Sriuranpong V Pinto DS Jr Gutkind JS Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma. Neoplasia 2006 8 733-746 1584297 16984731 10.1593/neo.06274
79. Yang J Liao X Agarwal MK Barnes L Auron PE Stark GR Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NF{kappa}B. Genes Dev 2007 21 1396-1408 10.1101/gad.1553707 17510282
80. Dong G Lee TL Yeh NT Geoghegan J Van Waes C Chen Z Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor. Oncogene 2004 23 6199-6208 10.1038/ sj.onc.1207851 15221009
81. Gumucio DL Heilstedt-Williamson H Gray TA Tarle SA Shelton DA Tagle DA Slightom JL Goodman M Collins FS Phylogenetic footprinting reveals a nuclear protein which binds to silencer sequences in the human gamma and epsilon globin genes. Mol Cell Biol 1992 12 4919 4929 360424 1406669
82. Zhang Z Gerstein M Of mice and men: Phylogenetic footprinting aids the discovery of regulatory elements. J Biol 2003 2 11 193683 12814519 10.1186/1475-4924-2-11
83. Zhang YF Homer C Edwards SJ Hananeia L Lasham A Royds J Sheard P Braithwaite AW Nuclear localization of Y-box factor YB1 requires wild-type p53. Oncogene 2003 22 2782 2794 10.1038/sj.onc.1206357 12743601
84. Sinha S Kim IS Sohn KY de Crombrugghe B Maity SN Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex. Mol Cell Biol 1996 16 328 337 231007 8524312
85. Maity SN de Crombrugghe B Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends Biochem Sci 1998 23 174 178 10.1016/ S0968-0004(98)01201-8 9612081
86. Mantovani R The molecular biology of the CCAAT-binding factor NF-Y. Gene 1999 239 15 27 10.1016/S0378-1119(99)00368-6 10571030
87. Kim IS Sinha S de Crombrugghe B Maity SN Determination of functional domains in the C subunit of the CCAAT-binding factor (CBF) necessary for formation of a CBF-DNA complex: CBF-B interacts simultaneously with both the CBF-A and CBF-C subunits to form a heterotrimeric CBF molecule. Mol Cell Biol 1996 16 4003 4013 231396 8754798
88. Sinha S Maity SN Lu J de Crombrugghe B Recombinant rat CBF-C, the third subunit of CBF/NFY, allows formation of a protein-DNA complex with CBF-A and CBF-B and with yeast HAP2 and HAP3. Proc Natl Acad Sci USA 1995 92 1624 1628 42572 7878029 10.1073/pnas.92.5.1624
89. Romier C Cocchiarella F Mantovani R Moras D The NF-YB/NF-YC structure gives insight into DNA binding and transcription regulation by CCAAT factor NF-Y. J Biol Chem 2003 278 1336 1345 10.1074/jbc.M209635200 12401788
90. Imbriano C Gurtner A Cocchiarella F Di Agostino S Basile V Gostissa M Dobbelstein M Del Sal G Piaggio G Mantovani R Direct p53 transcriptional repression: In vivo analysis of CCAAT-containing G2/M promoters. Mol Cell Biol 2005 25 3737 3751 1084283 15831478 10.1128/ MCB.25.9.3737-3751.2005
91. Oikawa T ETS transcription factors: Possible targets for cancer therapy. Cancer Sci 2004 95 626 633 10.1111/j.1349-7006.2004.tb03320.x 15298723
92. Bassuk AG Anandappa RT Leiden JM Physical interactions between Ets and NF-kappaB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. J Virol 1997 71 3563 3573 191503 9094628
93. Graves BJ Petersen JM Specificity within the ets family of transcription factors. Adv Cancer Res 1998 75 1 55 9709806
94. Oikawa T Yamada T Molecular biology of the Ets family of transcription factors. Gene 2003 303 11 34 10.1016/S0378-1119(02)01156-3 12559563
95. Bai L Logsdon C Merchant JL Regulation of epithelial cell growth by ZBP-89: Potential relevance in pancreatic cancer. Int J Gastrointest Cancer 2002 31 79 88 10.1385/IJGC:31:1-3:79 12622418
96. Bai L Merchant JL ZBP-89 promotes growth arrest through stabilization of p53. Mol Cell Biol 2001 21 4670 4683 87140 11416144 10.1128/ MCB.21.14.4670-4683.2001
97. Remington MC Tarle SA Simon B Merchant JL ZBP-89, a Kruppel-type zinc finger protein, inhibits cell proliferation. Biochem Biophys Res Commun 1997 237 230 234 10.1006/bbrc.1997.7119 9268691
98. Borghaei RC Rawlings PL Jr Javadi M Woloshin J NF-kappaB binds to a polymorphic repressor element in the MMP-3 promoter. Biochem Biophys Res Commun 2004 316 182 188 1595538 15003528 10.1016/j.bbrc.2004.02.030
99. Keates AC Keates S Kwon JH Arseneau KO Law DJ Bai L Merchant JL Wang TC Kelly CP ZBP-89, Sp1, and nuclear factor-kappa B regulate epithelial neutrophil-activating peptide-78 gene expression in Caco-2 human colonic epithelial cells. J Biol Chem 2001 276 43713 43722 10.1074/ jbc.M107838200 11559712
100. Chen Z Lee TL Yang XP Dong G Loercher A Van Waes C cDNA microarray and bioinformatic analysis of nuclear factor-kappaB related genes in squamous cell carcinoma. Cancer Genomics and Proteomics: Methods and Protocols Totowa, NJ: Humana Press Fisher PD 2007 383
101. Eisen MB Spellman PT Brown PO Botstein D Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998 95 14863 14868 24541 9843981 10.1073/pnas.95.25.14863
102. Stanford software: Significant Analysis of Microarray http://www-stat.stanford.edu/~tibs/SAM/
103. Saldanha AJ Java Treeview: Extensible visualization of microarray data. Bioinformatics 2004 20 3246 3248 10.1093/bioinformatics/bth349 15180930
104. Tempelman RJ Assessing statistical precision, power, and robustness of alternative experimental designs for two color microarray platforms based on mixed effects models. Vet Immunol Immunopathol 2005 105 175 186 10.1016/j.vetimm.2005.02.002 15808299
105. Wolfinger RD Gibson G Wolfinger ED Bennett L Hamadeh H Bushel P Afshari C Paules RS Assessing gene significance from cDNA microarray expression data via mixed models. J Comput Biol 2001 8 625 637 10.1089/ 106652701753307520 11747616
106. Gene Ontology: Database http://www.godatabase.org
107. National Center for Biotechnology Information http://www.ncbi.nlm.nih.gov
108. Genomatix Software GmbH http://www.genomatix.de
109. Hoh J Jin S Parrado T Edington J Levine AJ Ott J The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci USA 2002 99 8467 8472 124275 12077306 10.1073/pnas.132268899
110. Bajic VB Tan SL Chong A Tang S Strom A Gustafsson JA Lin CY Liu ET Dragon ERE Finder version 2: A tool for accurate detection and analysis of estrogen response elements in vertebrate genomes. Nucleic Acids Res 2003 31 3605 3607 168924 12824376 10.1093/nar/gkg517
111. Benos PV Lapedes AS Stormo GD Probabilistic code for DNA recognition by proteins of the EGR family. J Mol Biol 2002 323 701 727 10.1016/ S0022-2836(02)00917-8 12419259
112. Cartharius K Frech K Grote K Klocke B Haltmeier M Klingenhoff A Frisch M Bayerlein M Werner T MatInspector and beyond: Promoter analysis based on transcription factor binding sites. Bioinformatics 2005 21 2933 2942 10.1093/bioinformatics/bti473 15860560
113. Quandt K Frech K Karas H Wingender E Werner T MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 1995 23 4878 4884 307478 8532532 10.1093/nar/23.23.4878
114. Hughes JD Estep PW Tavazoie S Church GM Computational identification of cis-regulatory elements associated with groups of functionally related genes in Saccharomyces cerevisiae. J Mol Biol 2000 296 1205 1214 10.1006/ jmbi.2000.3519 10698627
115. Werner T Promoters can contribute to the elucidation of protein function. Trends Biotechnol 2003 21 9 13 10.1016/S0167-7799(02)00003-3 12480345
116. Dohr S Klingenhoff A Maier H Hrabe de Angelis M Werner T Schneider R Linking disease-associated genes to regulatory networks via promoter organization. Nucleic Acids Res 2005 33 864 872 549397 15701758 10.1093/ nar/gki230